Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection

Liver Int. 2019 Jul;39(7):1237-1245. doi: 10.1111/liv.14172. Epub 2019 Jun 26.

Abstract

Background and aims: Different population genetics studies showed that interactions between killer-cell immunoglobulin-like receptors (KIR) and HLA play a role in viral disease outcome, but functional correlates are missing. Building upon our previous work pointing to a regulatory role for KIR3DL1/DS1 in hepatitis C virus (HCV) infection, we analysed whether its expression may affect natural killer (NK) cell function in the presence or absence of its principal ligand HLA-Bw4 in KIR haplotype A and B carriers, which are characterized by a different representation of activating and inhibitory KIRs.

Methods: We performed KIR and HLA class I genotypic analysis in 54 healthy donors (HD) and 50 HCV+ subjects and examined NK cell cytokine secretion and degranulation in the context of KIR3DL1-HLA-Bw4 match stratified by KIR haplotype.

Results: KIR3DL1-HLA-Bw4 match induced functional NK cell modulation, reflected by reduced interferon (IFN)γ production in haplotype B HCV+ patients compared to HD. This functional impairment could be ascribed to the KIR3DS1 negative HCV-infected patient population, whose NK cells also showed a significantly decreased proportion of KIR3DL1. Haplotype A HCV-infected patients showed increased NK cell degranulation compared with HD in the absence of KIR-HLA-Bw4 match and this activity was associated with increased phosphorylation of signal transducer and activator of transcription (STAT) 1.

Conclusions: Our data show that NK cells from HCV+ patients have an unbalanced ability to produce IFNγ and to kill target cells in haplotype A and B carriers, suggesting the existence of complex functional differences governed by KIR-HLA interaction, particularly on KIR3DL1 expressing NK cells.

Keywords: Hepatitis C virus; KIR; NK cells; interferon-γ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Female
  • Genotype
  • HLA-B Antigens / genetics*
  • Haplotypes
  • Hepatitis C / immunology*
  • Heterozygote
  • Humans
  • Interferon-gamma / immunology*
  • Killer Cells, Natural / immunology*
  • Male
  • Middle Aged
  • Receptors, KIR3DL1 / genetics
  • Receptors, KIR3DL1 / physiology*
  • Young Adult

Substances

  • HLA-B Antigens
  • HLA-Bw4 antigen
  • KIR3DL1 protein, human
  • Receptors, KIR3DL1
  • Interferon-gamma